drugset / Trial / NCT01286207
Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)
RandomizedParallel-groupSingle-blindTreatment
Summary
This record describes pooled data for three extension studies: MK-0462-022 (NCT00897949); MK-0462-025 (NCT00899379); and MK-0462-029 (NCT00897104). These studies examined the long-term safety and efficacy of rizatriptan used for the treatment of acute migraine and migraine recurrence.
Timeline
- Start
- 1995-03
- Primary completion
- 1997-05
- Completion
- 1997-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rizatriptan | Unknown | 5 mg | Oral |
| Subject | rizatriptan | Unknown | 10 mg | Oral |